MediPress Health-Limited Partnership (TLV:MPRS)

Market Cap	6.67M -27.2%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	15.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Open	44.50
Previous Close	44.40
Day's Range	44.40 - 44.50
52-Week Range	41.50 - 75.70
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TLV:MPRS

MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 202...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: MPRS

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 12, 2026

Data Sources Report a data error